共 43 条
[1]
Tefferi A(2010)Novel mutations and their functional and clinical relevance in myeloproliferative neoplasms: JAK2, MPL, TET2, ASXL1, CBL, IDH and IKZF1 Leukemia 24 1128-1138
[2]
Kosmider O(2010)Mutations of IDH1 and IDH2 genes in early and accelerated phases of myelodysplastic syndromes and MDS/myeloproliferative neoplasms Leukemia 24 1094-1096
[3]
Gelsi-Boyer V(2010)Distinct clinical and biological features of Blood 116 4086-4094
[4]
Slama L(2010) acute myeloid leukemia with additional sex comb-like 1 (ASXL1) mutations Blood 115 2003-2007
[5]
Dreyfus F(2008)Clonal analysis of TET2 and JAK2 mutations suggests that TET2 can be a late event in the progression of myeloproliferative neoplasms Leukemia 22 1806-1807
[6]
Beyne-Rauzy O(2010)Multiple sub-microscopic genomic lesions are a universal feature of chronic myeloid leukaemia at diagnosis Leukemia 24 1146-1151
[7]
Quesnel B(2011)IDH1 and IDH2 mutation analysis in chronic- and blast-phase myeloproliferative neoplasms Leukemia 25 178-181
[8]
Chou WC(2010)IDH2 somatic mutations in chronic myeloid leukemia patients in blast crisis Leukemia 24 1139-1145
[9]
Huang HH(undefined)High-density single nucleotide polymorphism array analysis and ASXL1 gene mutation screening in chronic myeloid leukemia during disease progression undefined undefined undefined-undefined
[10]
Hou HA(undefined)undefined undefined undefined undefined-undefined